Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy

Abstract EN

Sarcoma is comprised of a heterogeneous group of tumors originating from the mesenchyme.

Sarcoma is also the first tumor that responded to immunotherapeutic agents often termed as “Coley’s toxins.” However, immunotherapy is yet to establish its presence in sarcomas.

Complex interactions between tumor and immune cells in the tumor microenvironment play a crucial role in response to immunotherapy.

There is a dynamic equilibrium created by the immune cells infiltrating the tumor, and this forms the basis of tumor evasion.

Manipulating the intratumoral microenvironment will help overcome tumor evasion.